Shares of Veradigm Inc. (NASDAQ:MDRX – Get Free Report) have received a consensus recommendation of “Hold” from the five ratings firms that are presently covering the company, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $14.75.
Several equities research analysts have recently commented on MDRX shares. Royal Bank of Canada reduced their price objective on Veradigm from $22.00 to $11.00 and set an “outperform” rating for the company in a research note on Friday, January 19th. StockNews.com initiated coverage on shares of Veradigm in a report on Friday. They issued a “hold” rating for the company. Stephens reaffirmed an “equal weight” rating and issued a $13.00 target price on shares of Veradigm in a report on Tuesday, November 14th. Finally, Barclays initiated coverage on shares of Veradigm in a report on Wednesday, January 3rd. They issued an “equal weight” rating and a $11.00 target price for the company.
Veradigm Stock Performance
NASDAQ:MDRX opened at $9.40 on Friday. Veradigm has a one year low of $8.68 and a one year high of $18.13. The business has a fifty day moving average price of $10.55 and a 200-day moving average price of $12.27.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in MDRX. Bank of New York Mellon Corp boosted its holdings in shares of Veradigm by 3.1% during the 1st quarter. Bank of New York Mellon Corp now owns 1,323,414 shares of the software maker’s stock valued at $29,803,000 after purchasing an additional 39,210 shares during the last quarter. Citigroup Inc. boosted its holdings in shares of Veradigm by 1.8% during the 1st quarter. Citigroup Inc. now owns 118,927 shares of the software maker’s stock valued at $2,678,000 after purchasing an additional 2,157 shares during the last quarter. Natixis Advisors L.P. raised its position in shares of Veradigm by 23.8% during the 1st quarter. Natixis Advisors L.P. now owns 86,478 shares of the software maker’s stock valued at $1,948,000 after buying an additional 16,642 shares in the last quarter. Bank of Montreal Can raised its position in shares of Veradigm by 3.6% during the 1st quarter. Bank of Montreal Can now owns 34,210 shares of the software maker’s stock valued at $768,000 after buying an additional 1,198 shares in the last quarter. Finally, MetLife Investment Management LLC raised its position in shares of Veradigm by 57.0% during the 1st quarter. MetLife Investment Management LLC now owns 68,294 shares of the software maker’s stock valued at $1,538,000 after buying an additional 24,794 shares in the last quarter.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.